EUVIMEDEUVIMED entdecken
Open Access

Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells

William H Palmer iD, Laura Ann Leaton iD, Ana Campos Codo iD, Bergren Crute iD, James Roest iD, Shiying Zhu, Jan Petersen iD, Richard P Tobin iD, Patrick S Hume iD, Matthew Stone, Adrie van Bokhoven iD, Mark E Gerich iD und 10 weitere

Science Immunology · 2023

DOI: 10.1126/sciimmunol.ade5343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, 2023. Verfasst von William H Palmer und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Killer Cells, Natural. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most human killer cell immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) cells and recognize HLA class I molecules as ligands. KIR3DL3 is a conserved but polymorphic inhibitory KIR recognizing a B7 family ligand, HHLA2, and is implicated for immune checkpoint targeting. The expression profile and biological function of KIR3DL3 have been somewhat elusive, so we searched extensively for KIR3DL3 transcripts, revealing highly enriched expression in γδ and CD8 + T cells rather than NK cells. These KIR3DL3-expressing cells are rare in the blood and thymus but more common in the lungs and digestive tract. High-resolution flow cytometry and single-cell transcriptomics showed that peripheral blood KIR3DL3 + T cells have an activated transitional memory phenotype and are hypofunctional. The T cell receptor (TCR) usage is biased toward genes from early rearranged TCR-α variable segments or Vδ1 chains. In addition, we show that TCR-mediated stimulation can be inhibited through KIR3DL3 ligation. Whereas we detected no impact of KIR3DL3 polymorphism on ligand binding, variants in the proximal promoter and at residue 86 can reduce expression. Together, we demonstrate that KIR3DL3 is up-regulated alongside unconventional T cell stimulation and that individuals may vary in their ability to express KIR3DL3. These results have implications for the personalized targeting of KIR3DL3/HHLA2 checkpoint inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesKiller Cells, NaturalHumansLigandsThymus GlandReceptors, Antigen, T-Cell, alpha-betaImmunoglobulinsReceptors, KIR

Substanzen

LigandsReceptors, Antigen, T-Cell, alpha-betaHHLA2 protein, humanImmunoglobulinsKIR3DL3 protein, humanReceptors, KIR

Autor:innen und Institutionen

  • Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO, USA.
  • Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Department of Surgery, Division of Surgical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Department of Medicine, National Jewish Health, Denver, CO, USA.
  • Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.

ORCID-Profile: William H Palmer, Laura Ann Leaton, Ana Campos Codo, Bergren Crute, James Roest, Jan Petersen, Richard P Tobin, Patrick S Hume, Adrie van Bokhoven, Mark E Gerich, Martin D McCarter, Yuwen Zhu, William J Janssen, Julian P Vivian, John Trowsdale, Jamie Rossjohn, John Cambier, Liyen Loh, Paul J Norman

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Palmer, W. H., Leaton, L. A., Campos Codo, A., Crute, B., Roest, J., Zhu, S., Petersen, J., Tobin, R. P., Hume, P. S., Stone, M., van Bokhoven, A., Gerich, M. E., McCarter, M. D., Zhu, Y., Janssen, W. J., Vivian, J. P., Trowsdale, J., Getahun, A., Rossjohn, J., …, & Norman, P. J. (2023). Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells. Science Immunology. https://doi.org/10.1126/sciimmunol.ade5343

Vancouver

Palmer WH, Leaton LA, Campos Codo A, Crute B, Roest J, Zhu S, et al. Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells. Science Immunology. 2023. doi:10.1126/sciimmunol.ade5343

BibTeX
@article{Palmer2023,
  author = {Palmer, William H and Leaton, Laura Ann and Campos Codo, Ana and Crute, Bergren and Roest, James and Zhu, Shiying and Petersen, Jan and Tobin, Richard P and Hume, Patrick S and Stone, Matthew and van Bokhoven, Adrie and Gerich, Mark E and McCarter, Martin D and Zhu, Yuwen and Janssen, William J and Vivian, Julian P and Trowsdale, John and Getahun, Andrew and Rossjohn, Jamie and Cambier, John and Loh, Liyen and Norman, Paul J},
  title = {Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells},
  journal = {Science Immunology},
  year = {2023},
  doi = {10.1126/sciimmunol.ade5343}
}
Kostenlos starten →